Document de presse | 2020.07.27
Resistance to artemisinin, the main component of the current antimalarial treatments recommended by WHO, is already widespread in South-East Asia, but it had not previously been described in Africa. Scientists from the Institut Pasteur, in collaboration with the National Malaria Control Program in Rwanda (Rwanda Biomedical Center), the World Health Organization (WHO), Cochin Hospital and Columbia...
News | 2020.12.07
The Institut Pasteur International Network, with the support of the International Department of the Institut Pasteur (Paris) and in association with institutional funders, has mobilised to help certain member institutes in Africa and Asia to carry out their public health missions in the context of the management of the COVID-19 pandemic. The objective of this aid was to provide them with...
Document de presse | 2022.07.13
Bats are reservoir species for numerous viruses including coronaviruses. Given that they do not appear to be affected by diseases transmitted by these viruses, there is potential benefit in understanding how their immune system regulates infection. Scientists at the Institut Pasteur and the CNRS studied SARS-CoV-2 replication in bat cells, which involved using real-time imaging techniques for the...
Document de presse | 2023.01.25
Scientists from the Institut Pasteur, Necker-Enfants Malades Hospital (AP-HP), Inserm in the Imagine Institute, Université Paris Cité and the Alfort National Veterinary School (EnvA) have identified a previously unknown species of circovirus, provisionally named human circovirus 1 (HCirV-1). Circoviruses are a family of small, highly resistant DNA viruses that were initially identified in 1974 in...
Article | 2023.04.04
A 4-year Group leaders’ position is open at the Hellenic Pasteur Institute on one (1) of the following topics.
Portrait | 2023.10.02
Javier Pizarro-Cerda's upbringing gave him curiosity, an interest in biology and science, as well as a lifelong passion for music! After his studies in Costa Rica, he came to Europe to become a scientist.Today at the Institut Pasteur in Paris, his research on plague and other Yersinia infections follows on from the work of his predecessors and also explores the history of deadly epidemics of the...
News | 2023.12.18
While the main outcome of COP28 was an agreement calling on the parties to "transition away from fossil fuels" with the aim of limiting climate change, it was also the first COP to include a Health Day. Rising global temperatures, extreme meteorological phenomena and ecosystem change are not merely environmental concerns. They are catalysts of a silent epidemic that is affecting human health....
Document de presse | 2024.04.26
After a 2022/2023 season marked by a severe epidemic of bronchiolitis due to respiratory syncytial virus (RSV), in particular in terms of emergency department visits and hospital admissions, on September 15, 2023 the French Government launched a preventive immunization campaign, administering nirsevimab (Beyfortus®), to protect infants and reduce the circulation of the virus.To assess the...
News | 2022.10.05
The Institut Pasteur is continuing to celebrate the bicentenary of Louis Pasteur's birth by organizing a major conference in December and also by partnering with events organized by other institutions and participating in official 2022 bicentenary festivals and conferences. Check out the calendar of events below and at www.pasteur2022.fr.
News | 2024.07.03
On June 25, 2024, the Institut Pasteur hosted the second edition of Pasteur Innov'Day. The goal was to demonstrate the potential of the Institut Pasteur's research and innovation continuum to industry players in the health sector. The event was attended by almost 150 partners (startups, SMEs, major pharmaceutical corporations, investors, and other innovation stakeholders) as well as many Institut...